Chronic alcoholism can result in alcoholic liver disease. Current treatment methods for alcoholic liver injury primarily include abstinence, drug therapy, and surgical treatment. However, these methods have their own shortcomings – abstinence does not cure alcoholic liver disease, drug therapy can produce negative side effects, and surgical treatment is often accompanied by risks, specifically liver rejection. Therefore, it is especially important to find a safe and effective method to ameliorate alcoholic liver disease. Probiotics, as natural microorganisms in the human intestine, can effectively alleviate alcoholic liver disease due to their unique properties. While Lactiplantibacillus (Lpb.) plantarum, a representative strain of probiotics, has been shown to exert beneficial effects against alcoholic liver injury, the underlying mechanism is unclear. In this study, a murine model of alcoholic liver injury was established in C57BL/6 mice by feeding mice a Lieber-DeCarli diet for 2 weeks. This model was then utilised to assess the potential protective mechanism of Lpb. plantarum LP4. The results demonstrated that Lpb. plantarum LP4 could significantly decrease pro-inflammatory cytokines in serum and liver, thereby reducing the inflammatory response. Furthermore, treatment with Lpb. plantarum LP4 inhibited inflammation and oxidative stress in the liver by modulating several signalling pathways. In addition, Lpb. plantarum LP4 also prevented endotoxin-induced hepatic injury by protecting the integrity of the intestinal barrier. In conclusion, Lpb. plantarum LP4 can effectively alleviate alcoholic liver injury in C57BL/6 mice.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Åberg, F., Jiang, Z.G., Cortez-Pinto, H. and Männistö, V., 2024. Alcohol-associated liver disease – Global epidemiology. Hepatology 80: 1307-1322. https://doi.org/10.1097/hep.0000000000000899
Beringer, A., Thiam, N., Molle, J., Bartosch, B. and Miossec, P., 2017. 08.03 Il-17 and TNF-α induce in synergy an inflammatory response in hepatocytes through il-6-dependent and –independent pathways. Annals of the Rheumatic Diseases 76: A75-A76. https://doi.org/10.1136/annrheumdis-2016-211055.3
Deng, R.-M. and Zhou, J., 2023. Targeting NF-κB in hepatic ischemia–reperfusion alleviation: from signaling networks to therapeutic targeting. Molecular Neurobiology 61: 3409-3426. https://doi.org/10.1007/s12035-023-03787-w
Ding, Y. and Chen, Q., 2023. The NF-κB pathway: a focus on inflammatory responses in spinal cord injury. Molecular Neurobiology 60: 5292-5308. https://doi.org/10.1007/s12035-023-03411-x
Dubey, A.K., Podia, M., Priyanka Raut, S., Singh, S., Pinnaka, A.K. and Khatri, N., 2021. Insight into the beneficial role of Lactiplantibacillus plantarum supernatant against bacterial infections, oxidative stress, and wound healing in A549 cells and BALB/c mice. Frontiers in Pharmacology 12: 728614. https://doi.org/10.3389/fphar.2021.728614
Fang, T.J., Guo, J.-T., Lin, M.-K., Lee, M.-S., Chen, Y.-L. and Lin, W.-H., 2019. Protective effects of Lactobacillus plantarum against chronic alcohol-induced liver injury in the murine model. Applied Microbiology and Biotechnology 103: 8597-8608. https://doi.org/10.1007/s00253-019-10122-8
Galle-Treger, L., Helou, D.G., Quach, C., Howard, E., Hurrell, B.P., Muench, G.R.A., Shafiei-Jahani, P., Painter, J.D., Iorga, A., Dara, L., Emamaullee, J., Golden-Mason, L., Rosen, H.R., Soroosh, P. and Akbari, O., 2022. Autophagy impairment in liver CD11c + cells promotes non-alcoholic fatty liver disease through production of IL-23. Nature Communications 13: 1440. https://doi.org/10.1038/s41467-022-29174-y
Garcia-Gonzalez, N., Battista, N., Prete, R. and Corsetti, A., 2021. Health-promoting role of Lactiplantibacillus plantarum isolated from fermented foods. Microorganisms 9: 349. https://doi.org/10.3390/microorganisms9020349
Ghareghomi, S., Moosavi-Movahedi, F., Saso, L., Habibi-Rezaei, M., Khatibi, A., Hong, J. and Moosavi-Movahedi, A.A., 2023. Modulation of Nrf2/HO-1 by natural compounds in lung cancer. Antioxidants 12: 735. https://doi.org/10.3390/antiox12030735
Günzel, D. and Fromm, M., 2012. Claudins and other tight junction proteins. In: Comprehensive Physiology. Wiley, pp. 1819-1852. https://doi.org/10.1002/cphy.c110045
Gupta, D., Lessard, S., Moore, N., Duan, J., Nakamura, Y., Yang, F.-C., Hicks, A., Light, D.R. and Krishnamoorthy, S., 2019. Genetic activation of NRF2 by KEAP1 inhibition induces fetal hemoglobin expression and triggers anti-oxidant stress response in erythroid cells. Blood 134: 210. https://doi.org/10.1182/blood-2019-129479
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514. https://doi.org/10.1038/nrgastro.2014.66
Horowitz, A., Chanez-Paredes, S.D., Haest, X. and Turner, J.R., 2023. Paracellular permeability and tight junction regulation in gut health and disease. Nature Reviews Gastroenterology and Hepatology 20: 417-432. https://doi.org/10.1038/s41575-023-00766-3
Idalsoaga, F., Ayares, G., Dı́az, L.A., Arnold, J., Ayala-Valverde, M., Hudson, D., Arrese, M. and Arab, J.P., 2023. Current and emerging therapies for alcohol-associated hepatitis. Liver Research 7: 35-46. https://doi.org/10.1016/j.livres.2023.03.002
Ignatenko, G.A., Bondarenko, N.N., Dubovaya, A.V., Ignatenko, T.S., Valigun, Y.S., Belyaeva, E.A. and Gavrilyak, V.G., 2024. Hypoxia-inducible factors: details create a picture. Part II. HIF-2. Fundamental and Clinical Medicine 8: 85-100. https://doi.org/10.23946/2500-0764-2023-8-4-85-100
Inmaculada, N.-G., Álvaro, S.-F. and Francisco, G.-C., 2012. Overexpression, purification, and biochemical characterization of the esterase Est0796 from Lactobacillus plantarum WCFS1. Molecular Biotechnology 54: 651-660. https://doi.org/10.1007/s12033-012-9607-7
Izumi, Y. and Koyama, Y., 2024. Nrf2-independent anti-inflammatory effects of dimethyl fumarate: challenges and prospects in developing electrophilic Nrf2 activators for neurodegenerative diseases. Antioxidants 13(12): 1527. https://doi.org/10.3390/antiox13121527
Kim, H.J., Zheng, M., Kim, S.-K., Cho, J.J., Shin, C.H., Joe, Y. and Chung, H.T., 2011. CO/HO-1 induces NQO-1 expression via Nrf2 activation. Immune Network 11: 376-382. https://doi.org/10.4110/in.2011.11.6.376
Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., Yeh, M., McCullough, A.J., Sanyal, A.J. and The Nonalcoholic Steatohepatitis Clinical Research Network, 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6): 1313-1321. https://doi.org/10.1002/hep.20701
Kreimeyer, H., Llorente, C. and Schnabl, B., 2025. Influence of alcohol on the intestinal immune system. Alcohol Research: Current Reviews 45: 03. https://doi.org/10.35946/arcr.v45.1.03
Lei, X., Teng, W., Fan, Y., Zhu, Y., Yao, L., Li, Y. and Zhu, S., 2022. The protective effects of HIF-1α activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis. PLoS ONE 17: e0268445. https://doi.org/10.1371/journal.pone.0268445
Li, F., Duan, K., Wang, C., McClain, C. and Feng, W., 2016. Probiotics and alcoholic liver disease: treatment and potential mechanisms. Gastroenterology Research and Practice 2016: 5491465. https://doi.org/10.1155/2016/5491465
Li, J., Li, Q., Wu, Q., Gao, N., Wang, Z., Yang, Y. and Shan, A., 2023. Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway. Journal of Animal Science and Biotechnology 14: 23. https://doi.org/10.1186/s40104-023-00830-7
Li, S., Hong, M., Tan, H.-Y., Wang, N. and Feng, Y., 2016. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxidative Medicine and Cellular Longevity 2016: 4234061. https://doi.org/10.1155/2016/4234061
Liu, H., Guo, S., Wei, S., Liu, J. and Tian, B., 2024. Pharmacokinetics and pharmacodynamics of cyclodextrin-based oral drug delivery formulations for disease therapy. Carbohydrate Polymers 329: 121763. https://doi.org/10.1016/j.carbpol.2023.121763
Madkour, L.H., 2020. Oxidative stress and oxidative damage-induced cell death. In: Madkour, L.H. (ed.) Reactive Oxygen Species (ROS), Nanoparticles, and Endoplasmic Reticulum (ER) Stress-Induced Cell Death Mechanisms. Academic Press, Cambridge, MA, USA, pp. 175-197. https://doi.org/https://doi.org/10.1016/B978-0-12-822481-6.00008-6
Maheshwari, S., Gu, C.N., Caserta, M.P., Kezer, C.A., Shah, V.H., Torbenson, M.S., Menias, C.O., Fidler, J.L. and Venkatesh, S.K., 2024. Imaging of alcohol-associated liver disease. American Journal of Roentgenology 222: e2329917. https://doi.org/10.2214/ajr.23.29917
Martins-Gomes, C., Nunes, F.M. and Silva, A.M., 2024. Natural products as dietary agents for the prevention and mitigation of oxidative damage and inflammation in the intestinal barrier. Antioxidants 13: 65. https://doi.org/10.3390/antiox13010065
Mosoian, A., Zhang, L., Hong, F., Cunyat, F., Rahman, A., Bhalla, R., Panchal, A., Saiman, Y., Fiel, M.I., Florman, S., Roayaie, S., Schwartz, M., Branch, A., Stevenson, M. and Bansal, M.B., 2017. Frontline science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS. Journal of Leukocyte Biology 101: 1083-1090. https://doi.org/10.1189/jlb.3HI0516-242R
Nicoletti, A., Ponziani, F.R., Biolato, M., Valenza, V., Marrone, G., Sganga, G., Gasbarrini, A., Miele, L. and Grieco, A., 2019. Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation. World Journal of Gastroenterology 25: 4814-4834. https://doi.org/10.3748/wjg.v25.i33.4814
Poznyak, V. and Rekve, D., 2015. The impact of alcohol consumption on global health. Tackling Harmful Alcohol Use 81. https://doi.org/10.1787/9789264181069-7-en
Raina, K., Agarwal, C. and Agarwal, R., 2013. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling. Molecular Carcinogenesis 52: 195-206. https://doi.org/10.1002/mc.21843
Rao, X., Huang, X., Zhou, Z. and Lin, X., 2013. An improvement of the 2̂(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, Bioinformatics and Biomathematics 3: 71-85.
Robinson, K., Deng, Z., Hou, Y. and Zhang, G., 2015. Regulation of the intestinal barrier function by host defense peptides. Frontiers in Veterinary Science 2: 57. https://doi.org/10.3389/fvets.2015.00057
Rodina, A.S., Shubina, M.E., Kurbatova, I.V., Topchieva, L.V. and Dudanova, O.P., 2021. Hepatocellular damage and inflammation in various forms of alcoholic liver disease. Terapevticheskii Arkhiv 93: 15-19. https://doi.org/10.26442/00403660.2021.01.200587
Segui-Perez, C., Stapels, D.A.C., Ma, Z., Su, J., Passchier, E., Westendorp, B., Wubbolts, R.W., Wu, W., van Putten, J.P.M. and Strijbis, K., 2024. MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C. Journal of Cell Science 137: jcs261468. https://doi.org/10.1242/jcs.261468
Seitz, H.K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G. and Tsukamoto, H., 2018. Alcoholic liver disease. Nature Reviews Disease Primers 4: 16. https://doi.org/10.1038/s41572-018-0014-7
Shao, T., Zhao, C., Li, F., Gu, Z., Liu, L., Zhang, L., Wang, Y., He, L., Liu, Y., Liu, Q., Chen, Y., Donde, H., Wang, R., Jala, V.R., Barve, S., Chen, S.-Y., Zhang, X., Chen, Y., McClain, C.J. and Feng, W., 2018. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. Journal of Hepatology 69: 886-895. https://doi.org/10.1016/j.jhep.2018.05.021
Shaw, P., Dwivedi, S.K.D., Bhattacharya, R., Mukherjee, P. and Rao, G., 2024. VEGF signaling: role in angiogenesis and beyond. Biochimica et Biophysica Acta – Reviews on Cancer 1879: 189079. https://doi.org/10.1016/j.bbcan.2024.189079
Slifer, Z.M. and Blikslager, A.T., 2020. The integral role of tight junction proteins in the repair of injured intestinal epithelium. International Journal of Molecular Sciences 21: 972. https://doi.org/10.3390/ijms21030972
Subramaniyan, V., Lubau, N.S.A., Mukerjee, N. and Kumarasamy, V., 2023. Alcohol-induced liver injury in signalling pathways and curcumin’s therapeutic potential. Toxicology Reports 11: 355-367. https://doi.org/10.1016/j.toxrep.2023.10.005
Thong, V.D. and Quynh, B.T.H., 2021. Correlation of serum transaminase levels with liver fibrosis assessed by transient elastography in Vietnamese patients with nonalcoholic fatty liver disease. International Journal of General Medicine 14: 1349-1355. https://doi.org/10.2147/IJGM.S309311
Toshikuni, N., 2014. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World Journal of Gastroenterology 20(26): 8393. https://doi.org/10.3748/wjg.v20.i26.8393
Ureña-Peralta, J.R., Pérez-Moraga, R., Garcı́a-Garcı́a, F. and Guerri, C., 2020. Lack of TLR4 modifies the miRNAs profile and attenuates inflammatory signaling pathways. PLoS ONE 15(8): e0237066. https://doi.org/10.1371/journal.pone.0237066
Usanova, A.A., Kuzma, F., Novikova, E.K. and Sergutova, N.P., 2024. Modern therapeutic approaches to the treatment of alcoholic hepatitis. Актуальные проблемы медицины 47: 158-170. https://doi.org/10.52575/2687-0940-2024-47-2-158-170
Wang, K., Lv, L., Yan, R., Wang, Q., Jiang, H., Wu, W., Li, Y., Ye, J., Wu, J., Yang, L., Bian, X., Jiang, X., Lu, Y., Xie, J., Wang, Q., Shen, J. and Li, L., 2020. Bifidobacterium longum R0175 protects rats against d-galactosamine-induced acute liver failure. mSphere 5: e00791-00719. https://doi.org/10.1128/mSphere.00791-19
Wang, Y., Yue, Y., Wang, H., Jiang, Y. and Shi, J., 2023. Oligochitosan glycosylation of casein by TGase: protective effect and mechanism on alcohol-induced intestinal injury in C57BL/6 mice. Journal of Functional Foods 111: 105892. https://doi.org/10.1016/j.jff.2023.105892
Yang, S., Kuang, G., Zhang, L., Wu, S., Zhao, Z., Wang, B., Yin, X., Gong, X. and Wan, J., 2020. Mangiferin attenuates LPS/D-GalN-induced acute liver injury by promoting HO-1 in Kupffer cells. Frontiers in Immunology 11: 285. https://doi.org/10.3389/fimmu.2020.00285
Yi, R., Tan, F., Liao, W., Wang, Q., Mu, J., Zhou, X., Yang, Z. and Zhao, X., 2019. Isolation and identification of Lactobacillus plantarum HFY05 from natural fermented yak yogurt and its effect on alcoholic liver injury in mice. Microorganisms 7: 530. https://doi.org/10.3390/microorganisms7110530
Yu, H., Lin, L., Zhang, Z., Zhang, H. and Hu, H., 2020. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduction and Targeted Therapy 5(1): 209. https://doi.org/10.1038/s41392-020-00312-6
Zhang, X.-l., Wu, Y.-f., Wang, Y.-s., Wang, X.-z., Piao, C.-h., Liu, J.-m., Liu, Y.-l. and Wang, Y.-h., 2017. The protective effects of probiotic-fermented soymilk on high-fat diet-induced hyperlipidemia and liver injury. Journal of Functional Foods 30: 220-227. https://doi.org/10.1016/j.jff.2017.01.002
Zhang, Y., Liu, J., Wang, S., Luo, X., Li, Y., Lv, Z., Zhu, J., Lin, J., Ding, L. and Ye, Q., 2016. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners. Oncotarget 7: 23740-23756. https://doi.org/10.18632/oncotarget.8060
Zhang, Z., Yang, H., Han, F. and Guo, P., 2025. Reactive oxygen species as key molecules in the pathogenesis of alcoholic fatty liver disease and nonalcoholic fatty liver disease: future perspectives. Current Issues in Molecular Biology 47(6): 464. https://doi.org/10.3390/cimb47060464
Zhao, L., Jiang, Y., Ni, Y., Zhang, T., Duan, C., Huang, C., Zhao, Y., Gao, L. and Li, S., 2017. Protective effects of Lactobacillus plantarum C88 on chronic ethanol-induced liver injury in mice. Journal of Functional Foods 35: 97-104. https://doi.org/10.1016/j.jff.2017.05.017
Zhu, L., Li, H.-D., Xu, J.-J., Li, J.-J., Cheng, M., Meng, X.-M., Huang, C. and Li, J., 2022. Advancements in the alcohol-associated liver disease model. Biomolecules 12: 1035. https://doi.org/10.3390/biom12081035
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 125 | 125 | 67 |
| Full Text Views | 5 | 5 | 2 |
| PDF Views & Downloads | 17 | 17 | 7 |
Chronic alcoholism can result in alcoholic liver disease. Current treatment methods for alcoholic liver injury primarily include abstinence, drug therapy, and surgical treatment. However, these methods have their own shortcomings – abstinence does not cure alcoholic liver disease, drug therapy can produce negative side effects, and surgical treatment is often accompanied by risks, specifically liver rejection. Therefore, it is especially important to find a safe and effective method to ameliorate alcoholic liver disease. Probiotics, as natural microorganisms in the human intestine, can effectively alleviate alcoholic liver disease due to their unique properties. While Lactiplantibacillus (Lpb.) plantarum, a representative strain of probiotics, has been shown to exert beneficial effects against alcoholic liver injury, the underlying mechanism is unclear. In this study, a murine model of alcoholic liver injury was established in C57BL/6 mice by feeding mice a Lieber-DeCarli diet for 2 weeks. This model was then utilised to assess the potential protective mechanism of Lpb. plantarum LP4. The results demonstrated that Lpb. plantarum LP4 could significantly decrease pro-inflammatory cytokines in serum and liver, thereby reducing the inflammatory response. Furthermore, treatment with Lpb. plantarum LP4 inhibited inflammation and oxidative stress in the liver by modulating several signalling pathways. In addition, Lpb. plantarum LP4 also prevented endotoxin-induced hepatic injury by protecting the integrity of the intestinal barrier. In conclusion, Lpb. plantarum LP4 can effectively alleviate alcoholic liver injury in C57BL/6 mice.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 125 | 125 | 67 |
| Full Text Views | 5 | 5 | 2 |
| PDF Views & Downloads | 17 | 17 | 7 |